RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Alligator Bioscience EBIT 2024

Alligator Bioscience EBIT

-48.07 M SEK

Alligator Bioscience Dividend yield

Ticker

ATORX.ST

ISIN

SE0000767188

WKN

A2AN1Z

In 2024, Alligator Bioscience's EBIT was -48.07 M SEK, a -80.73% increase from the -249.39 M SEK EBIT recorded in the previous year.

The Alligator Bioscience EBIT history

YEAREBIT (undefined SEK)
2026e-159.09
2025e-206.69
2024e-48.07
2023-249.39
2022-192.3
2021-141.36
2020-144.04
2019-213.17
2018-152.18
2017-63.03
2016-33.96
2015213.09
2014-77.21

Alligator Bioscience Aktienanalyse

What does Alligator Bioscience do?

Alligator Bioscience AB is a biopharmaceutical company based in Lund, Sweden. The company was founded in 2001 and specializes in the development of innovative cancer therapies that harness the body's immune system to fight tumor cells. The company's business model is based on the research, development, and commercialization of biological drugs using highly specialized technologies such as antibody research and immuno-oncology. Alligator Bioscience works closely with leading research institutions and partners in the biotechnology and pharmaceutical industries. Its main focus is on developing antibodies against cancer using its patented technology platforms ALLIGATOR-GOLD® and ALLIGATOR-FAB®. These antibodies are highly effective, safe, and have a low side effect profile. Another important area of Alligator Bioscience's work is immuno-oncology, which involves activating and enhancing the body's own immune system to target and destroy cancer cells. The company has developed a range of innovative drugs in various stages of clinical development. One of its key products is ATOR-1017, a monoclonal antibody that targets the OX40 T-cell receptor and has shown promising results in activating the immune system against cancer in clinical trials. ADC-1013, an antibody targeting the PD-1 receptor, is another promising drug in development for the treatment of various types of cancer. Alligator Bioscience has a diverse portfolio of products and drugs focused on fighting cancer and works closely with research partners and customers to improve the effectiveness and safety of its products for market release. In summary, Alligator Bioscience is a leading company in cancer research and therapy, with an innovative technology platform and highly specialized drugs that have shown promising results. The company is continuously working to develop new and better cancer therapies. Alligator Bioscience ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Alligator Bioscience's EBIT

Alligator Bioscience's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Alligator Bioscience's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Alligator Bioscience's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Alligator Bioscience’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Alligator Bioscience Stock

How much did Alligator Bioscience achieve in EBIT for the current year?

In the current year, Alligator Bioscience has achieved an EBIT of -48.07 M SEK.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Alligator Bioscience.

How has the EBIT of Alligator Bioscience developed in recent years?

The EBIT of Alligator Bioscience has increased by -80.726% decreased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Alligator Bioscience?

The EBIT of Alligator Bioscience is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Alligator Bioscience pay?

Over the past 12 months, Alligator Bioscience paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Alligator Bioscience is expected to pay a dividend of 0 SEK.

What is the dividend yield of Alligator Bioscience?

The current dividend yield of Alligator Bioscience is .

When does Alligator Bioscience pay dividends?

Alligator Bioscience pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Alligator Bioscience?

Alligator Bioscience paid dividends every year for the past 0 years.

What is the dividend of Alligator Bioscience?

For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.

In which sector is Alligator Bioscience located?

Alligator Bioscience is assigned to the 'Health' sector.

Wann musste ich die Aktien von Alligator Bioscience kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Alligator Bioscience from 5/20/2024 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 5/20/2024.

When did Alligator Bioscience pay the last dividend?

The last dividend was paid out on 5/20/2024.

What was the dividend of Alligator Bioscience in the year 2023?

In the year 2023, Alligator Bioscience distributed 0 SEK as dividends.

In which currency does Alligator Bioscience pay out the dividend?

The dividends of Alligator Bioscience are distributed in SEK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Alligator Bioscience

Our stock analysis for Alligator Bioscience Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Alligator Bioscience Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.